^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    EasyPGX® Ready KRAS

    Company:
    Diatech Pharmacogenetics
    Type:
    CE-IVDR (New IVDR)
    Related tests:

    Details

    Evidence
    News
    Detection of major mutations in exon 2 (codons 12, 13), exon 3 (codons 59, 61) and exon 4 (codons 117, 146) of the KRAS gene using an 8 oligo mix. Each mix allows for co-amplification of one or more mutated alleles plus an endogenous control gene. A specific oligo control mix allows for evaluation of the quality and quantity of DNA in each sample.ext to product
    Cancer:
    Cholangiocarcinoma, Colorectal Cancer, Non Small Cell Lung Cancer, Thyroid Gland Carcinoma
    Gene:
    KRAS (KRAS proto-oncogene GTPase)
    Method:
    real-time PCR